Ajanta Pharma Limited

AJANTPHARM.BO·BSE·Healthcare
Compare
3,282.00−31.55 (−0.95%)today
At close: Nov 5, 3:29 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close3,313.55
Open3,328.25
Day range3,269.903,346.90
52-week range2,022.053,346.90
Off day high−1.94%
Off 52-week high−1.94%
Volume49.30K
Avg. volume (3M)7.66K
Market cap410.04B
EPS (TTM)81.11
Forward P/E33.02
P/E ratio (TTM)40.46
Dividend yield1.98% (56.00)
Beta (5Y)0.16
Shares outstanding124.94M
Short interest—
Earnings dateJul 28, 2025 (est.)
Analyst target3,207.58
Profit margin19.50%

Against its peers

Compare in full ›
AJANTPHARM.BO AUROPHARMA.NS JUBLPHARMA.BO IPCALAB.NS ASTRAZEN.NS APLLTD.NS
Market cap 410.04B 1.03T 150.00B 494.62B 157.35B 175.63B
P/E (TTM) 40.5 25.9 42.7 37.8 92.8 20.8
Forward P/E 33.0 19.0 18.7 27.7 — 18.2
Price/book 9.5 2.6 2.1 6.1 18.0 3.0
Dividend yield 1.98% — 0.53% 0.30% 0.57% 1.32%
1-year change +4.72% +49.48% −19.11% +51.13% −30.65% −0.94%
Today −0.95% +4.69% +0.79% −1.14% −1.16% −1.46%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Univest·Negative

Ajanta Pharma Share Price Fall Streak After Second Drop

Ajanta Pharma Share Price Fall Streak has now run into a second straight session, with the stock last traded at Rs 3,499.75, down 2.3% for the day, and the company valued at Rs 44,762.82 crore. The price move is confirmed in Univest data;…

From the 4Search news index, newest first.

In the news

1mentions in 30 days
1with it in the headline
Negativesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance